NCT02596360View on ClinicalTrials.gov

Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Experimental PainHyperalgesia
Interventions
DRUG

Pulmodexane® 30mg

The study design is divided in two study sequences and each subject participates in the two study sequences and receive the two treatments (dextromethorphan and placebo).

DRUG

lactose

The study design is divided in two study sequences and each subject participates in the two study sequences and receive the two treatments (dextromethorphan and placebo).

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT02596360 - Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers | Biotech Hunter | Biotech Hunter